Mangalam Organics Ltd (MANORG)

📊 Quarterly Results (₹ Cr)

The company has demonstrated accelerating revenue growth, with consolidated revenue rising from Rs. 158 crore in September 2025 to Rs. 179 crore in June 2026, and OPM improving to 9% from negative levels earlier in the fiscal year. However, profitability remains volatile, with operating profit margin fluctuating between -3.7% and 23.6% over the past four quarters, indicating sensitivity to input costs and pricing pressures. Net profit rose to Rs. 7 crore in June 2026 from Rs. 3 crore in September 2025, but the company reported a cash flow outflow of Rs. 8 crore from operations in March 2025, suggesting working capital intensity or timing lags in cash conversion.

🔮 Management Outlook & What's Next

Management has explicitly signaled confidence in future growth through strategic investments in sustainable chemical production and expansion of high-margin segments like terpene derivatives and synthetic resins. The approval of a Rs. 1,500 crore borrowing limit indicates intent to fund future capex or working capital needs without equity dilution. Management also emphasized export markets and high-value applications as growth levers, while acknowledging raw material volatility and global commodity exposure as key risks. No specific revenue or margin targets were provided, but the focus on sustainability and domestic demand positioning suggests a long-term view of market share gain.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet shows a steady increase in total assets from Rs. 624 crore in March 2025 to Rs. 740 crore in March 2026, driven by growth in reserves and borrowings. Borrowings rose to Rs. 359 crore from Rs. 268 crore YoY, reflecting increased reliance on debt to support expansion. Equity remains stable at Rs. 9 crore, with reserves growing from Rs. 285 crore to Rs. 310 crore, suggesting retained earnings are being capitalized. The leverage ratio of 0.91 is moderate, but the company is using debt to finance growth rather than returning capital, which aligns with its expansion phase. The strong asset growth without proportional equity increases raises concerns about financial efficiency if returns do not improve.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Promoter holding remains stable at 58.65% across all recent quarters, indicating no dilution or stake sale. Institutional ownership is minimal, with FII holding at 0% consistently, while DII holdings have slightly increased from 3.63% to 2.21% in Q1FY27, though still low. The number of public shareholders has marginally declined from 16,361 to 14,522, suggesting possible consolidation. No insider selling or significant institutional accumulation is evident, and the company has issued reminders about unclaimed dividends, which may reflect shareholder disengagement or administrative inertia. Overall, retail and institutional interest remains limited despite strong financials.

⚖️ Peer Comparison — Chemicals

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Raw material cost volatility is explicitly flagged as a key risk, with management highlighting exposure to commodity price swings affecting margins. 2. The company's profitability remains inconsistent, as seen in fluctuating OPM and negative cash flow from operations in prior periods, raising concerns about operational efficiency. 3. High leverage and asset-heavy expansion increase financial risk, especially if growth does not translate into sustainable cash flows. 4. Low institutional and DII interest, coupled with a declining number of public shareholders, may limit liquidity and market depth, increasing volatility.

📋 Recent Filings

• 🟡 Board Meeting2026-09-26Mangalam Organics shareholders approved the appointment of JMT & Associates as statutory auditors for five years starting from the 44th AGM on Septemb…
• Announcement2026-09-26Mangalam Organics announced the closure of its trading window from October 1, 2026, to prevent insider trading ahead of releasing unaudited financial …
• 🔴 Insider Trading2026-09-25Mangalam Organics disclosed that Tradechem Organics, its promoter group, created a pledge on 11,36,370 shares (13.27% of total equity) to secure a loa…
• 🟡 Board Meeting2026-09-24Mangalam Organics held its 44th AGM on September 24, 2026 via video conference, approving audited financials, director reappointments, related party t…
• 🟡 Board Meeting2026-09-23Mangalam Organics announced the death of Non-Executive Independent Director Sidharath Singh Sekhon on September 23, 2026, effective immediately, marki…
• 🔴 annual report2026-08-29Mangalam Organics disclosed that its 44th Annual General Meeting is scheduled for September 24, 2026, via video conference, and shared the web link to…
• 🟡 Board Meeting2026-08-29Mangalam Organics Ltd announced its 44th AGM on September 24, 2026, via video conferencing, where shareholders will vote on key resolutions including …
• 🔴 annual report2026-08-29Mangalam Organics Ltd (MANORG) reported a 17.46% revenue increase to Rs 623 crore for FY2025-26, with profit after tax surging 103% to Rs 25.38 crore,…
• 🔴 Corporate Action2026-08-13Mangalam Organics Limited issued a reminder to shareholders about unclaimed dividends for FY 2018-19, warning that shares may be transferred to the In…
• Announcement2026-07-30Mangalam Organics presented its Q1 FY27 investor deck on July 30, 2026, highlighting 22.2% revenue growth YoY to ₹179.09 crores and a 22.21 crores PAT…

🧠 Analyst's Read

Mangalam Organics is executing a clear expansion strategy supported by strong revenue and profit growth, but the path to value creation hinges on converting scale into durable margins and cash flow. Investors should monitor the outcome of the upcoming AGM decisions, particularly the use of enhanced borrowing capacity and the impact of raw material costs on profitability. The company's success in scaling sustainable chemical segments and managing working capital will be critical to sustaining its upward trajectory.

Based on filing content and financial data. Not a recommendation.